Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer
Ryohei Yoshida(Asahikawa Medical University), Yoshinobu Ohsaki(Asahikawa Medical University)
Cited by 34
Related Papers
The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer
|Oncology Letters|2021|7
SETD2 and miR-21 as therapeutic targets for NUT midline carcinoma
|Research Square|2021|0